Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases

Annals of the Rheumatic Diseases

Volumn 70, Issue 6, 2011, Pages 1068-1073

  Saad, Carla G S ^a   Borba, Eduardo F ^a   Aikawa, Nadia E ^a   Silva, Clovis A ^a   Pereira, Rosa M R ^a   Calich, Ana Luisa ^a   Moraes, Julio C B ^a   Ribeiro, Ana C M ^a   Viana, Vilma S T ^a   Pasoto, Sandra G ^a   Carvalho, Jozelio F ^a   França, Ivan L A ^a   Guedes, Lissiane K N ^a   Shinjo, Samuel K ^a   Sampaio Barros, Percival D ^a   Caleiro, Maria T ^a   Goncalves, Celio R ^a   Fuller, Ricardo ^a   Levy Neto, Mauricio ^a   Timenetsky, Maria Do Carmo S ^a   Precioso, Alexander R ^b   Bonfa, Eloisa ^a   more..

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; PREDNISONE;

ADULT; ANKYLOSING SPONDYLITIS; ANTIPHOSPHOLIPID SYNDROME; AORTA ARCH SYNDROME; ARTHRALGIA; ARTICLE; AUTOIMMUNE DISEASE; BEHCET DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DERMATOMYOSITIS; DIARRHEA; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA VACCINATION; INJECTION SITE COLORATION; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; MYALGIA; NOSE CONGESTION; POLYMYOSITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIATIC ARTHRITIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RHINORRHEA; SEROCONVERSION; SJOEGREN SYNDROME; SORE THROAT; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; WEGENER GRANULOMATOSIS;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIBODIES, VIRAL; AUTOIMMUNE DISEASES; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; RHEUMATIC DISEASES; VACCINATION; YOUNG ADULT;

EID: 79955790531     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2011.150250     Document Type: Article

References (44)

1. Centers for Disease Control and Prevention (CDC). Update: influenza activity - United States, August 30, 2009-January 9, 2010. MMWR Morb Mortal Wkly Rep 2010 ; 59 : 38-43.
2. Centers for Disease Control and Prevention. Questions & Answers: Vaccine Selection for the 2010-2011 Influenza Season. http://www.cdc.gov/flu/ about/qa/1011-vac-selection.htm ( accessed 12 January 2011 ).
3. van Assen S, Agmon-Levin N, Elkayam O, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011 ; 70 : 414-22.
4. Fiore A E, Uyeki TM, Broder K, et al.; Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010 ; 59 : 1-62.
5. Tebas P, Frank I, Lewis M, et al.; Center for AIDS Research and Clinical Trials Unit of the University of Pennsylvania. Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals. AIDS 2010 ; 24 : 2187-92.
6. Bickel M, Wieters I, Khaykin P, et al. Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients. AIDS 2010 ; 24 : F31-5.
7. Issa N C, Marty FM, Gagne LS, et al. Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2011 ; 17 : 434-8.
8. Lu C C, Wang YC, Lai JH, et al. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine 2011 ; 29 : 444-50.
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 ; 40 : 1725.
10. Arnett F C, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 ; 31 : 315-24. (Pubitemid 18091653) (Pubitemid 18091653)
11. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984 ; 27 : 361-8. (Pubitemid 14134775) (Pubitemid 14134775)
12. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980 ; 23 : 581-9.
13. Taylor W, Gladman D, Helliwell P, et al. ; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006 ; 54 : 2665-73. (Pubitemid 44205029) (Pubitemid 44205029)
14. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990 ; 335 : 1078-80.
15. Kasukawa R, Tojo T, Miyawaki S, et al. Preliminary diagnostic criteria for mixed connective tissue disease. In : Kasukawa R, Sharp G., eds. Mixed Connective Tissue Disease and Anti-Nuclear Antibodies. Amsterdam; New York, NY; Oxford : Excerpta Medica 1987 : 41-7.
16. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 ; 4 : 295-306.
17. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975 ; 292 : 344-7.
18. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis 1996 ; 55 : 116-21.
19. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990 ; 33 : 1129-34. (Pubitemid 20273298) (Pubitemid 20273298)
20. Leavitt R Y, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990 ; 33 : 1101-7. (Pubitemid 20273294) (Pubitemid 20273294)
21. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992 ; 35 : 630-40.
22. Kendal AP, Pereira MS, Skehel JJ., eds. Concepts and Procedures from Laboratory-Based Influenza Surveillance. Atlanta, GA : Centers for Disease Control and Prevention, 1982.
23. Liang X F, Wang HQ, Wang JZ, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010 ; 375 : 56-66.
24. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009 ; 361 : 1945-52.
25. Agmon-Levin N, Paz Z, Israeli E, et al. Vaccines and autoimmunity. Nat Rev Rheumatol 2009 ; 5 : 648-52.
26. Shoenfeld Y, Agmon-Levin N. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011 ; 36 : 4-8.
27. Crowe B A, Brühl P, Gerencer M, et al. Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans. Vaccine 2010 ; 29 : 166-73.
28. Scharpé J, Peetermans WE, Vanwalleghem J, et al. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Am J Kidney Dis 2009 ; 54 : 77-85.
29. Scharpé J, Evenepoel P, Maes B, et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008 ; 8 : 332-7.
30. Cook IF. Sexual dimorphism of humoral immunity with human vaccines. Vaccine 2008 ; 26 : 3551-5.
31. Holvast A, de Haan A, van Assen S, et al. Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis. Ann Rheum Dis 2010 ; 69 : 924-7.
32. Setti M, Fenoglio D, Ansaldi F, et al. Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients. Vaccine 2009 ; 27 : 3367-72.
33. Wiesik-Szewczyk E, Romanowska M, Mielnik P, et al. Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. Clin Rheumatol 2010 ; 29 : 605-13.
34. Abu-Shakra M, Press J, Buskila D, et al. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenecity issues. Autoimmun Rev 2007 ; 6 : 543-6. (Pubitemid 47374614) (Pubitemid 47374614)
35. Holvast A, van Assen S, de Haan A, et al. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Rheumatology (Oxford) 2009 ; 48 : 1294-9.
36. Holvast A, van Assen S, de Haan A, et al. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Arthritis Rheum 2009 ; 60 : 2438-47.
37. Conti F, Rezai S, Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev 2008 ; 8 : 124-8.
38. Salemi S, Picchianti-Diamanti A, Germano V, et al. Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity. Clin Immunol 2010 ; 134 : 113-20.
39. Waddington C, Andrews N, Hoschler K, et al. Open-label, randomised, parallelgroup, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus nonadjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. Health Technol Assess 2010 ; 14 : 1-130.
40. Bingham CO, 3rd, Looney RJ, Deodhar A, et al. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum 2010 ; 62 : 64-74.
41. van Assen S, Holvast A, Benne CA, et al. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum 2010 ; 62 : 75-81.
42. Gelinck L B, van der Bijl AE, Beyer WE, et al. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 2008 ; 67 : 713-16. (Pubitemid 351571939) (Pubitemid 351571939)
43. Elkayam O, Bashkin A, Mandelboim M, et al. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 2010 ; 39 : 442-7.
44. Agmon-Levin N, Kivity S, Shoenfeld Y. Influenza vaccine and autoimmunity. Isr Med Assoc J 2009 ; 11 : 183-5.